Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology • Medical Oncology • Hematology • Benign Hematology • Hemostasis/Thrombosis
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?
Do social or economic factors (i.e., relative cost of acquiring LMWH, the patient being injection averse) affect your decision to use DOACs?
Do you still use the port if it is functioning well?
Answer from: Medical Oncologist at Community Practice
The initial trials that established DOACs as effective and safe in most patients with cancer-associated thrombosis (Agnelli et al., PMID 32223112, Planquette et al., PMID 34627853) only included patients with lower-extremity DVT or PE but clearly showed equivalence to low-molecular weight heparin (w...
Sign in or Register to read more